ESR1 and breast cancer: Expression of ER and p53 is mutually regulated through a feedback loop. While ER upregulates p53 expression by protein stabilization and transcriptional regulation, p53 upregulates ER again. That may explain why mutations in p53 would inhibit ER expression, decreasing the effects of tamoxifen in breast cancer and leading to drug resistance.